Lung Cancer Insights: What’s New in the Field – October Update
This overview summarizes recent international advances in lung cancer research. The highlighted studies include real-world evaluations of immunotherapy and targeted agents, consensus definitions for surgical staging, and biomarker-guided adjuvant strategies. Major global trials report improved outcomes with novel EGFR-, HER2-, and KRAS-directed therapies, as well as combination approaches in advanced disease. Together, these studies offer an updated overview of current developments and directions in lung cancer research and clinical management.
